Archives — April 2014 back to current month (46)

Duncan Hughes' Quartet of High-Grade Winners (04/30/2014)

With gold hovering around $1,300 an ounce, there's not much room for error, says Duncan Hughes of RFC Ambrian. In this interview with The Gold Report, Hughes counsels that investors should seek high-grade, low-cost projects with exploration upside in stable jurisdictions. He suggests three such companies in West Africa and another with silver, gold and antimony resources in Chile and Australia.

more>

6 Drugs that Could Move the Pharma Market (04/30/2014)

"It's estimated that as many as 76 new drugs could be launched worldwide this year, a cohort capable of generating as much as $23B by 2019."

more>

Ed Sterck: Russian Sanctions May Have Utilities Squeezing Less Juice from Uranium Supply (04/29/2014)

Russia is a commodities giant, but supply isn't the major issue—enrichment is. With a 44% global market share, Russia's enrichment industry allows utilities around the world to squeeze more juice out of fewer lemons. In other words, Russian sanctions could mean utilities will have to use more natural uranium to make lemonade. That's how Edward Sterck sees it, and the uranium mining analyst for BMO Capital Markets predicts a supply deficit by 2018. In this interview with The Mining Report, Sterck delivers a comprehensive uranium market overview and shares uranium names that can juice profits in lean times.

more>

New Melanoma Therapies Are Ready for Prime Time: Sanjiv Agarwala (04/29/2014)

Melanoma confronts patients and their physicians with unique barriers to treatment and successful outcomes. In this interview with The Life Sciences Report, Dr. Sanjiv Agarwala, chief of medical oncology and hematology at St. Luke's University Hospital, illuminates some of the new paradigms being developed in the treatment of this deadly skin cancer. Along the way, he spotlights interesting companies working in the field.

more>

Wind Energy Dominates US Power Under Construction (04/29/2014)

"For the first quarter of 2014, the Federal Energy Regulatory Commission found that renewable energy sources, primarily wind and solar, made up more than 90 percent of new installed power capacity, with natural gas making up the remainder."

more>

China Holds the Keys to the Gold Market (04/28/2014)

"We are witnessing China transform into an economic powerhouse, and now, the world's largest gold market!."

more>

Thibaut Lepouttre's Commodity Plays in a Sideways Market (04/28/2014)

Metals prices have been trading sideways for some time. How can you make gains in your portfolio when commodity prices are in a stalemate? In this interview with The Gold Report, Thibaut Lepouttre, editor of Caesars Report, talks about ways to play metals from gold to copper and tungsten in a market with weak price movement, and scans the globe to find 11 potential winners.

more>

New, More Transparent, Contracts to End Africa's Resource Curse? (04/28/2014)

"African nations are now much more 'up to speed' with what they should be demanding by way of a fair share of the resources being mined in their countries. New contracts are much tougher and some are being drafted with the idea of transparency and even online publication in mind."

more>

These Alternative Energy Stocks Will Soar on China's Rare Metal War (04/25/2014)

"In 2012, production and consumption of the rare earth metals used in production of clean tech reached more than 100,000 metric tons, according to IHS Chemical. Today, the vast bulk of materials needed to build these technologies come primarily from China."

more>

Charles Duncan: 2014 Is for Careful Stock Pickers, Not Dart Throwers (04/24/2014)

Veteran Senior Biotechnology Analyst Charles Duncan of Piper Jaffray & Co. sees platform companies as the perfect way to play a consolidating market. We've had a big run in biotech, and Duncan believes now is the time to identify, through careful diligence, companies that can advance in a more temperate market. In this interview with The Life Sciences Report, Duncan discusses five biotech and specialty pharma innovators poised to produce therapies enabled by versatile and scalable technology platforms that target multiple disease indications.

more>

Andrew Coleman Wants to Know if You Are Ready for the Global Oil Surplus (04/24/2014)

As North America continues to produce more oil and gas than the world knows what to do with, Raymond James Analyst Andrew Coleman thinks the sector is likely to remain sluggish. But if investing is a bit of a poker game, you need to learn to read the table if you want the best chance at a winning hand. In this interview with The Energy Report, Coleman explains the international supply/demand disparity and tells us which oil and gas producers he values highest in an uncertain energy market.

more>

Prepared for the Attack of the Short Sellers: Joe Reagor (04/23/2014)

Wall StreetDespite the ongoing attack of the short-sellers, the fundamentals of gold and silver production are increasingly robust. ROTH Capital's Joe Reagor tells The Gold Report why he believes the price of gold is steaming toward $1,500/oz, with silver prices following in the wake. Reagor highlights several junior precious metals miners in a market that is out to prove the bears on Wall Street wrong.

more>

How Will Gold Respond to Declining Discovery? (04/23/2014)

"At $1,900 per ounce of gold, even mediocre finds could make money."

more>

Why Energy Is Catching the Market's Eye (04/23/2014)

"In a spectacularly performing market during 2013, energy lacked some of the incredible performance seen throughout the other sectors, but recently it has turned up, catching the attention of the market yet again."

more>

Do the Math: Ram Selvaraju on the Appeal of Biotechs in Orphan Diseases (04/22/2014)

To cast a spotlight on disruptive biotechnology stocks, Raghuram "Ram" Selvaraju of Aegis Capital Corp. taps his experience as a molecular biologist, preclinical investigator and sellside analyst. In this, the last of his three interviews with The Life Sciences Report, Selvaraju highlights micro-, small- and mid-cap biotech names with therapies that may add years to patients' lives and liftoff to investor portfolios.

more>

Night of the Living Dead Miners: Rare Earth 'Zombies' Attack the ASX and TSX (04/22/2014)

In 2010, rare earth and specialty metals market froth had speculators throwing money at a sector they didn't understand, and opportunistic resource company managers stepped up to take their money. Two years later, so-called zombies, the walking dead companies, lurk on the TSX and ASX exchanges, all talk and no product. As Richard Karn of Emerging Trends Report explains in his interview with The Mining Report, anemic cash flows will put many of these zombies to rest in the coming year, while the survivors—the companies that can drop a sample on an end-user's desk for evaluation—will finally see the light of day.

more>

The Traffic Jam that Kills Thousands of People Every Day (04/22/2014)

"But the real question is by not approving drugs in the renal and cardiac unit, did he also kill people by not acting? Are there consequences to not acting? Because sometimes by not acting, by being too careful, by making it too expensive, maybe we're killing more people than regulation is saving."

more>

Willem Middelkoop and Terence van der Hout: Turnaround Stories Revolve Around Proven Management (04/21/2014)

Willem Middelkoop and Terence van der Hout of the Netherlands-based Commodity Discovery Fund believe that when the world's reserve currency is reset away from the U.S. dollar in the next decade, gold prices will rise and mining equities will follow. Van der Hout and Middelkoop tell The Gold Report that by focusing on producers, near-producers and turnaround stories, they plan to capitalize on the opportunities in North America, Africa and beyond.

more>

Four Hidden Australian Life Sciences Growth Stocks Revealed: Scott Power (04/17/2014)

To find undiscovered stories, investors must venture into unfamiliar territory. In this interview with The Life Sciences Report, we go halfway around the world to speak with Scott Power of Morgans Financial Ltd. about companies under coverage in Australia. Power helps investors get comfortable with the idea of putting money into newfound names, and unveils four strong ideas that could invigorate adventuresome portfolios and investors hungering for excitement.

more>

Build Biotech Wealth on Solid Platforms: Grant Zeng (04/17/2014)

Potential. That's what every investor is looking for in a biotech investment. Grant Zeng of Zacks Small-Cap Research zeroes in on three primary factors when he looks at whether a particular company has the potential to succeed in the fast-moving life sciences industry. In this interview with The Life Sciences Report, Zeng dissects his process and names 10 companies that have survived his exacting examination.

more>

Do You Practice Quality of Life Investing? Michael Berry Does (04/17/2014)

Energy and food will be hot commodities as emerging middle classes start buying cars and beef. That is why, in this interview with The Energy Report, Discovery Investing Founder Michael Berry explains the importance of quality of life investing. Oil and gas, uranium and fertilizer stocks are on sale now, but might not be in the years to come.

more>

Latest GFMS Gold Survey Reports Record 2013 Gold Production (04/17/2014)

"GFMS puts 2013 new mine production of gold at a record 3,022 tonnes, a 6% gain over 2012."

more>

Why Ukraine's Gas Industry May Be the Most Profitable in the World (04/16/2014)

"Right now, the pipeline system is nothing but a conduit for Russian gas into Europe. It could be much more."

more>

Salman Partners' Raymond Goldie: Copper Is Pathological and Suffers from SAD, but It Has Value (04/16/2014)

Dr. Copper may be in a supercycle, but there are serious problems. In this interview with The Gold Report, Salman Partners' Vice President of Commodity Economics Raymond Goldie explains why even though the base metal acts pathologically and has a bad case of seasonal affective disorder, these six equities are priced below their intrinsic value.

more>

Sanctions for Russia? Here Are the Real Winners (04/16/2014)

"Russia is more than a major producer and exporter of energy and materials; Russia is also an important player within Western supply and product chains."

more>

Three Key Metrics to Identify a Superstar Investment (04/15/2014)

Etienne Moshevich, editor of Alphastox.com, looks at three things before he decides to get excited about a company: people, projects and structure. In this interview with The Mining Report, Moshevich explains his ground-up approach to evaluating junior resource companies and names the names that are set to rake in the profits.

more>

When the Major Equity Market Bubble Crashes, Michael Berry Will Take Refuge in These Gold Stocks (04/14/2014)

An overinflated equities market could be good news for metals and mining stocks. In this interview with The Gold Report, Morning Notes Publisher Michael Berry shares two scenarios that could follow an imminent crash and four gold companies that could be perfectly positioned to take advantage of a reset credit market.

more>

Gold Moving on Ukraine Crisis Escalation (04/14/2014)

"New Ukrainian tensions have seen the gold price rise in trading today as the West remains nervous about further escalation and the possible imposition of more rigorous economic sanctions."

more>

There Is No Biotech Bubble; Here's the Real Story (04/11/2014)

"The job in the startup phase is R&D, not market performance."

more>

Russia Invaded Crimea and These US Energy Companies Made a Killing: Stansberry Research's Matt Badiali Shares O&G Investing Strategies (04/10/2014)

Don't put all your investments in one stock, warns S&A Resource Report Editor Matt Badiali. In this interview with The Energy Report, he shares a basket of companies that are extracting higher margins with ever-evolving shale drilling methods. Find out about his top tenbagger opportunities at home, in the so-called new science and factory shales, as well as his favorites in the far reaches of Kurdistan, where an eventual takeover draft looks likely.

more>

Don't Miss the Boat on Big Biotech Catalysts: Keith Markey (04/10/2014)

Keith Markey, veteran analyst and science director of Griffin Securities, tells us the 2014 pipeline calendar positively glows with important milestones that could ignite portfolios. In this interview with The Life Sciences Report, Markey talks about four powerful biotech names with exciting early- to late-stage development projects, and one medical device and supply company with serious growth potential. Be warned—huge catalysts are on the horizon that investors won't want to miss.

more>

Hang On, Folks—It's Going to Be a Bumpy Ride: 2014 Biotech Watchlist Update (04/10/2014)

stethbillfold8214Biotech stocks sailed into 2014 backed by a favorable wind, but springtime has stymied the sector in confused seas. Companies on The Life Sciences Report's 2014 Biotech Watchlist have hit the doldrums along with the rest, as faithful followers of the portfolio are doubtless aware. But sector analysts defend the general robustness of the life sciences market as a whole. In this Biotech Watchlist update, we bring you the thoughts of two analysts on the recent market turbulence, and offer brief recaps of Watchlist companies' fortunes year to date.

more>

Manganese Miners and Indonesia's Export Ban (04/10/2014)

"Japan has sent a letter to Indonesia's foreign trade minister and will likely complain to the World Trade Organization about the ban and tariff structure, while copper industry heavyweight Freeport-McMoRan Copper & Gold has already signaled it may fail again to have a smelter ready by the extended deadline."

more>

Puerto Rico's Tax Benefits—More than 'The Better Florida' (04/09/2014)

Puerto Rico promises to do for Americans what Singapore and Hong Kong have done for bankers and businessmen from London. In this interview with The Gold Report, three experts with in-depth knowledge of the pros and cons of living and investing in Puerto Rico share what it is like on the ground for investors. InternationalMan.com Senior Editor Nick Giambruno and Casey Research Chief Technology Investor and Puerto Rico resident Alex Daley join Sterne Agee's Managing Director of Equity Research Todd Hagerman in clearing up some of the confusion about this "misunderstood" island and why the tax benefits for Americans make it "The Better Florida."

more>

Are You Prepared for a Bull Market that Will Shock Even the Most Ardent Goldbugs? (04/09/2014)

Jay Taylor understands why investors in gold and gold equities are consumed with caution. But the publisher and editor of J. Taylor's Gold, Energy & Tech Stocks and host of the radio show "Turning Hard Times into Good Times" urges them not to lose sight of the big picture. The big, bull-market picture. Gold juniors with cash and good projects are trading at tiny fractions of their worth. But not for long. In this interview with The Gold Report, Taylor argues that we are on the cusp of a bull market for the ages and suggests eight junior candidates for mind-blowing multiples.

more>

Zachary Schumacher's 'State of the Rare Earths' Address (04/08/2014)

As China's rare earth production winds down, other sources worldwide could shape up to reward early investors. But there are different ways to play this (slowly) growing market. Zachary Schumacher, international market analyst with Asian Metals, tells The Mining Report how investors can go medium or long on rare earths, and why joint venture and offtake partnerships are the biggest factors in creating value.

more>

Putting Money Where the Mouse Is: How Animal Studies Lead Medical Research Down Dead Ends (04/08/2014)

"If scientists had been more careful with their initial mouse studies, they would have realized that these drugs were never good candidates and that it made no sense to try them in people."

more>

Gold: Unearthing the World's Supply (04/08/2014)

"Within the earth's crust, there is only 1 gram of gold for every 550,000 pounds of earth."

more>

The Irresistible Future of Natural Gas (04/08/2014)

"After years of being forced to operate the old way, LNG is going to allow for the global movement of natural gas and the establishment of numerous local spot markets."

more>

Ted Dixon: What Gold Stock Insider Trading Tells Us (04/07/2014)

Despite the recent big gains in gold stocks, company insiders and institutional investors are still 2.5 times more likely to be buyers than sellers. According to Ted Dixon, cofounder and CEO of INK Research, this shows that those in the know are still quite bullish, despite the pullback in March. In this interview with The Gold Report, Dixon names the top insider buyers by dollar amount and by volume, and explains how investors should interpret this data.

more>

What's Abuzz About Gold? (04/07/2014)

"A key driver in gold prices is the real interest rate environment—the real rate of return taking into account the level of inflation."

more>

Raymond James' Pavel Molchanov Sees Stars in the Expanding Cleantech Universe (04/03/2014)

Cleantech, an outperformer in the energy space since 2012, experienced a major expansion phase in 2013 that is still unfolding. In this interview with The Energy Report, Raymond James Energy Analyst Pavel Molchanov points to companies with innovative technologies, strong balance sheets and financial flexibility as examples of low risk with high-flying rewards. Find out about his strongest Buy recommendation, as well as a special situation in big oil.

more>

Venture Capitalist Ran Nussbaum Brings Big Finance to Little Biotechs (04/03/2014)

Biotech companies don't come into the world fully formed. Like most fledglings, they need guidance to grow, prosper and eventually thrive in public markets. Venture capitalist Ran Nussbaum of the Pontifax Group nurtures tiny biotech and medtech startups, finding capital for their growth and maturation. In this interview with The Life Sciences Report, Nussbaum discusses exciting private equity holdings that are close to going public, and makes a case for one public company he knows quite well.

more>

How Did High Flyers Turn into Soul Searchers? Maxim Analyst Jason Kolbert on the Highs and Lows of Biotech Valuations (04/02/2014)

After soaring more than 56% last year, the NASDAQ Biotechnology Index is down almost 15% in March. In this interview with The Life Sciences Report, Jason Kolbert of the Maxim Group points to increased approval rates and a better economic and regulatory environment as the fundamentals behind a revaluation that has occurred in the sector. Kolbert also reflects on recent concerns about pricing and policy changes that have triggered what he considers a normal, healthy correction in an otherwise robust and intact sector.

more>

Looking for 1,000% Gains? Resource Investor Oliver Gross Has Some Junior Mining Names for You (04/02/2014)

The bottom is in, declares Oliver Gross of Der Rohstoff-Anleger (The Resource Investor), and the bulls are ready to charge. In this interview with The Gold Report, Gross says that the woefully undervalued juniors will exploit their leverage advantage, with best-in-class companies gaining as much as 500% to 1,000%—or more. And he lists more than a dozen gold, silver and copper companies most likely to soar.

more>

Stephan Bogner and the Rise of a Euro-Sino-Russian Superpower (04/01/2014)

Stephan Bogner, mining analyst with Rockstone Research and CEO of Elementum International, views the crisis in Crimea as the beginning of a larger global power shift east of the Atlantic. In this interview with The Mining Report, Bogner details what these shifting power dynamics will mean for the commodities market. And take heed—gold and silver may continue to make gains, but uranium, potash and rare earths are the true wave of the future.

more>

More Archives

2017Feb Jan

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2015Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2014Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2013Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2012Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Notable Quotes

"AVU transferred 85% of its interest in Slivovo to Byrnecut."
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"Hole 11 at EFR's Canyon showed 6 ft of 16.99% U3O8 and 1.2% copper."
– Brien Lundin, Gold Newsletter (Jefferson Financial)